Citadel Advisors’s Larimar Therapeutics LRMR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$145K	Buy	+32,200	New	+$129K	﹤0.01%	11715
2025 Q4	–	Sell	-288,200	Closed	-$931K	–	13491
2025 Q3	$931K	Buy	288,200 +238,100	+475%	+$893K	﹤0.01%	7681
2025 Q2	$145K	Sell	50,100 -1,500	-3%	-$3.47K	﹤0.01%	10993
2025 Q1	$111K	Buy	51,600 +24,400	+90%	+$77.1K	﹤0.01%	11318
2024 Q4	$105K	Buy	27,200 +3,100	+13%	+$20.5K	﹤0.01%	11408
2024 Q3	$158K	Sell	24,100 -12,400	-34%	-$99.7K	﹤0.01%	10501
2024 Q2	$265K	Sell	36,500 -72,200	-66%	-$553K	﹤0.01%	9386
2024 Q1	$825K	Buy	108,700 +106,400	+4,626%	+$829K	﹤0.01%	7345
2023 Q4	$10.5K	Sell	2,300 -2,100	-48%	-$7.08K	﹤0.01%	13103
2023 Q3	$17.4K	Buy	4,400 +2,200	+100%	+$8.32K	﹤0.01%	12732
2023 Q2	$6.89K	Buy	+2,200	New	+$8.98K	﹤0.01%	13398
2023 Q1	–	Sell	-100	Closed	-$413	–	15155
2022 Q4	$413	Buy	+100	New	+$341	﹤0.01%	14663
2022 Q3	–	Sell	-10,200	Closed	-$20K	–	13186
2022 Q2	$20K	Sell	10,200 -7,600	-43%	-$22.5K	﹤0.01%	12405
2022 Q1	$72K	Buy	+17,800	New	+$116K	﹤0.01%	12554
2016 Q1	–	Sell	-367	Closed	-$28K	–	7443
2015 Q4	$28K	Hold	367	–	–	﹤0.01%	7703
2015 Q3	$141K	Buy	+367	New	+$165K	﹤0.01%	6573